Related Experiment Video
Updated: Nov 24, 2025

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
Published on: February 7, 2015
Blood Cell Count Indexes of Systemic Inflammation in Carotid Artery Disease: Current Evidence and Future Perspectives
Paola Dettori1, Panagiotis Paliogiannis2, Rosa M Pascale2
1Center for Cure and Health, Sassari, Italy.
Insights
Blood cell count indexes, like neutrophil-to-lymphocyte ratio (NLR), may predict carotid artery disease and stroke risk. These inflammation markers offer insights into atherosclerotic processes and patient prognosis.
Area of Science:
- Vascular Medicine
- Hematology
- Inflammation Research
Background:
- Carotid artery disease (CAD) is a significant cause of ischemic stroke, accounting for about 30% of cases.
- Systemic inflammation plays a crucial role in the pathophysiology of atherosclerosis, the underlying mechanism of CAD.
- Biomarkers are needed for predicting CAD onset, progression, cerebrovascular events, and patient outcomes.
Purpose of the Study:
- To review the evidence on the utility of common blood cell count (BCC) indexes in carotid artery disease.
- To explore the role of BCC indexes in the diagnosis and risk stratification of patients with CAD.
- To discuss the potential clinical applications of these inflammatory markers in managing CAD.
Main Methods:
- Systematic review of existing literature on blood cell count indexes and carotid artery disease.
- Focus on specific BCC indexes: neutrophil-to-lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), platelet-to-lymphocyte ratio (PLR), mean platelet volume (MPV), platelet distribution width (PDW), and red cell distribution width (RDW).
- Analysis of studies investigating the association of these indexes with CAD diagnosis, progression, and cerebrovascular complications.
Main Results:
- Several BCC indexes, including NLR, MLR, PLR, MPV, PDW, and RDW, have shown associations with systemic inflammation.
- Evidence suggests these indexes may serve as predictors for the presence and severity of carotid artery stenosis.
- These markers have also been linked to an increased risk of cerebrovascular events in patients with CAD.
Conclusions:
- Commonly available BCC indexes represent accessible and potentially valuable tools for assessing systemic inflammation in CAD.
- These markers may aid in risk stratification and clinical decision-making for patients with carotid artery disease.
- Further research is warranted to establish definitive clinical guidelines for the use of BCC indexes in CAD management.
Abstract:
Carotid artery disease is commonly encountered in clinical practice and accounts for approximately 30% of ischemic strokes in the general population. Numerous biomarkers have been investigated as predictors of the onset and progression of carotid disease, the occurrence of cerebrovascular complications, and overall prognosis. Among them, blood cell count (BCC) indexes of systemic inflammation might be particularly useful, from a pathophysiological and clinical point of view, given the inflammatory nature of the atherosclerotic process. The aim of this review is to discuss the available evidence regarding the role of common BCC indexes, such as the neutrophil to lymphocyte ratio (NLR), monocyte to lymphocyte ratio (MLR), platelet to lymphocyte ratio (PLR), mean platelet volume (MPV), platelet distribution width (PDW), and red cell distribution width (RDW), in the diagnosis and risk stratification of carotid artery disease, and their potential clinical applications.
More Related Videos
06:04Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Inflammation
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...